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Changes in protein metabolism along with lipid exchange disorders have 
an essential practical bearing on the development of atherosclerosis. It is a 
matter of dysproteinemia in the plasma proteins*—a reduction of albumins 
and substantial rise of globulins (2, 3, 7, 8, 15), decreased protein synthesis 
in the arterial wall (5), reduced content of soluble protein in the liver and aorta 
(3), and diminished methionine accumulation in the organs of atherosclerotic 
animals (5, 10); 
On the other hand, an ever increasing number of authors underscore the 
effect of proteins and amino acids on serum cholesterol level and lipid infiltra­
tion in the organs (4, 6, 9, 17, 18, 20). S.-j. C. Yeh etal (1973) found a quicker 
turnover of the plasma cholesterol, and enhanced fecal excretion of neutral 
Steroids and cholic acids in rich in proteins diets. Y . Itokawa fet al (1973) ob­
served a marked hypocholesterolemic effect of sulfur-containing amino acids 
i n experimental atherosclerosis in rats. According to J . Kenney et al (1973), 
chickens fed a poor protein diet have a higher cholesterol level in the plasma 
and liver as compared to those fed a diet rich in proteins. I . Popdimitrov and 
K . Demireva (1975) found an elevated methionine — 7 6 Se accumulation in 
animals where cholesterol nutrition was supplemented by protein hydrolysate. 
Having in mind the literature data outlined above, we set out to verify 
the influence of protein hydrolysate "Hydroprot" (11) on serum lipids, ana 
on the development of lipoidosis in the aorta cf rats with experimentally in ­
duced atherosclerosis. 
Material and Methods 
The study was performed in a series of 243 male rabbits with weight rang­
ing from 2000—2700 g, divided into three groups: Г—with experimentally 
induced atherosclerosis after the method of Anichkov (each animal received 
0.2 g/kg weight cholesterol, dissolved in sunflower — seed oil added to the 
food; I I — with experimental atherosclerosis and daily subcutaneous injection 
.of protein hydrolysate at dose 5 ml/kg weight, and I I I — contrtils. Groups, I 
and I I I were injected with physiological saline at dose analogical to that lh 
; protein hydrolysate. Prior to the experiment, and periodically at 15-day irt-
tervals, venous blood was taken for serurh lipids' investigation. The animals 
were killed at 90 days after the beginning of'the experiment through exsan-
guination. Atherosclerotic changes along the intima of the aorta were recorded 
planimetrically after the method of .G. G . Avtandflov (1963) in part of thp 
laboratory animals!" 
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Serum cholesterol determination was carried out according to the method 
of S. Ilea (1962), beta-lipoproteins — after Burstein and Samaille, total lipids— 
after the method of Bloor as modified by J . H . Bragdon (1951), and phospholi­
pids — after the method of A. Svanborg and Z. Svennerholm (1961). 
Results 
Changes in the serum cholesterol level, followed up in dynamics, are pre-" 
sented in Fig. 1. The animals of group I display a rapid and considerable in 
crease in cholesterol. The difference relative to controls proves to be statisti" 
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cally reliable (p <0.01) within 15 days. The cholesterol rise is steady and unin* 
terrupted t i l l the end of the experiment (from 37.8 mg % it grows to 745.5 mg % ) 
steeper in the beginning, and less pronounced after the 60th day. In the ani­
mals of group I I , injected with protein hydrolysate, cholesterol is maintained 
at a lower level throughout the entire observation period. During the first 15 
days and at 60 days the differences are less marked, while the greatest differ­
ence is recorded at 45 (P<0.001) and 60 days (P<0.001). 
Beta-lipoproteins (Fig. 2) in group I show a steep rise till the end of the 
experiment, with a certain delay being recorded between the 60th and 75th day. 
In the protein hydrolysate group ( I I ) , following a 15-day adaptation period, 
a substantially weaker, wavy rise of beta-lipoproteins is observed, and within 
90 days all the values are statistically significantly lowered as compared to the 
animals of group one. 
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The steepest increase is noted in the total lipids' level. Among the animals 
in group I the total increase lipids from 336.7 mg% to 2238.8 mg%, while in 
group I I the increase observed is smaller (up to 1895.7). A reliable difference 
compared to group I is established in all periods of study, except for the first 
fifteen days (Fig. 3). 
In phospholipids alone the in­
crease in group I is less pronounced 
as compared to the animals of group 
two. A certain decrease occurs about 
the 75th day, followed by an in­
crease. The data concerning group 
I I show a uniform and steady 
rise parallel to the lengthening of 
the treatment period (Fig. 4). 
The morphological changes in the 
aorta of the animals of group I , meas­
ured with a planimetric ruler, consist 
in atherosclerotic alterations ranging 
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from 32.3 per cent to 56 per cent, and in isolated cases — up to 80 per cent 
cff the whole surface of the intima. Entire fields of confluent, rather clearcut, 
rough atherosclerotic changes are observed. The lipid deposits are most strongly 
pronounced in the arcus and chest tract of the aorta, they are slightly less 
manifested in the ascending part, and least to virtually absent — in the ab^ 
dominal aorta. The animals receiving protein hydrolysate (group I I ) show 
substantially less pronounced to absent lipid deposits. The changes fluctuate 
from 0.5 per cent to 15.2 per cent, and in sporadic cases they involve up to 
35 per cent of the intima surface. They are located mainly around the openings 
of the carotid artery and thoracic aorta. The lipid deposits are not roughly 
outlined, and reveal the form of single droplets or minute fields. 
{ 
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). , Discussion 
Our results show that protein hydrolysate administered to rabbits fed 
cholesterol diet exerts up to a great extent a protective action against athero­
sclerotic changes in the vessels. The fact that protein hydrolysate introduction 
teads to maintaining the serum lipids at a lower level, as compared to the ani-
tnals of group I , is of utmost importance. On the other hand, the constantly 
increasing phospholipids in their capacity of stabilizers of the colloid solutions, 
interfere with cholesterol deposition. Presumably the latter effect might be ascrib­
ed to the protective influence exerted by protein hydrolysate amino acids on the 
functions of the liver and other organs related to lipid metabolism wjaich is 
also supported by the histomorphological changes found by E \ Maleva and 
K. Demireva (1975). The presence of a complete constellation of irreplaceable 
and replaceable amino acids in the protein hydrolysate "Hydroprot" in all 
likelihood exerts a hydrocholesterolemic effect by way of the sulfur-contain­
ing amino acids' effect, established by Y . Itokawa et al (1973), or by means 
of activating the cholesterol turnover, established by S-j. C. Yeh et al (1973). 
Moreover, the stronger methionine 7 5 Se accumulation, demonstrated by I . Pbp-
dimitrov and K . Demireva (1975) in the organs of protein hydrolysate-treated 
animals under analogical experimental conditions, is interpreted as an ind i -
rect proof for a favourable influence on protein metabolism also. According 
to M. G. Kritzman (1967) the changes in protein metabolism appear to be the 
contributing factor in a great number of* diseases since the potential ability .of 
a mutual transition of inactive into active" protein is inherent of each protein 
structure thanks to the peculiar functionof amino acids to form plastic mate­
rial and biologically active substances. On the basis of the data referred to 
above the inference is reached that protein hydrolysate, applied to experimen­
tal atherosclerosis, exerts a protective action on protein and fat metabolism. 
Most probably, through the stabilization of protein structures within the organ­
ism, and first and foremost, enzyme systems (M. Shtereva and K . Demireva — 
1973) it obviates the disorders in the metabolism of substances, lipids ir\ par­
ticular. The results submitted in the work corroborate the opinion of a great 
number of authors about the pathogenic role played by protein metabolism 
disorders in the atherosclerotic process. 
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ВЛИЯНИЕ БЕЛКОВОГО ГИДРОЛИЗАТА НА АЛИМЕНТАРНУЮ 
ГИПЕРХОЛЕСТЕРОЛЕМИЮ И ЛИПОИДОЗ АОРТЫ У КРОЛИКОВ 
/С. Демирева 
Р Е З Ю М Е 
Прослежено влияние белкового гидролизата „гидропрот" на уровень 
холестерола сыворотки, бета-липопротеидов, общих липидов и фосфолипи-
дов у. кроликов с экспериментальным атеросклерозом. Исследования про­
ведены до опыта, на 15, 30, 45, 60, 75 и 90 день питания холестеролом и наз­
начения белкового гидролизата. 
Установлено, что после некоторого приспособительного периода к но­
вому режиму питания, парентеральное применение белкового гидролизата 
у животных с экспериментальным атеросклерозом приводит к задержива­
нию уровня холестерола сыворотки, общих липидов и бета-липопротеидов 
на более низком уровне, чем у животных не получающих белковый гидро-
лизат. Уровень фосфолипидов значительно выше до конца эксперимента. 
Атеросклеротические изменения интимы аорты выражены значительно 
слабее. Можно допустить, что этот результат обусловлен протективным 
воздействием аминокислот белкового гидролизата на нормальные функции 
печени и других органов, имеющих отношении к липоидному обмену. 
